The United Nations leader warned Monday that "the rule of force" was spreading, as the powerful trample on international law ...
Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...
HOLLYWOOD--God bless America, and how's everybody?
Zero-day exploits, AI-driven Android malware, firmware backdoors, password manager trust gaps, rising DDoS define this week’s critical cyber threats.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results